Tower Research Capital (TRC)’s ATAI Life Sciences ATAI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-13,549
| Closed | -$18K | – | 5174 |
|
2024
Q4 | $18K | Buy |
13,549
+1,274
| +10% | +$1.69K | ﹤0.01% | 3275 |
|
2024
Q3 | $14.2K | Sell |
12,275
-4,950
| -29% | -$5.74K | ﹤0.01% | 3470 |
|
2024
Q2 | $22.9K | Buy |
17,225
+8,555
| +99% | +$11.4K | ﹤0.01% | 3677 |
|
2024
Q1 | $17.1K | Sell |
8,670
-6,855
| -44% | -$13.5K | ﹤0.01% | 3138 |
|
2023
Q4 | $21.9K | Sell |
15,525
-14,205
| -48% | -$20K | ﹤0.01% | 3590 |
|
2023
Q3 | $38.4K | Sell |
29,730
-836
| -3% | -$1.08K | ﹤0.01% | 2790 |
|
2023
Q2 | $52.6K | Buy |
30,566
+15,151
| +98% | +$26.1K | ﹤0.01% | 2523 |
|
2023
Q1 | $28K | Sell |
15,415
-6,293
| -29% | -$11.4K | ﹤0.01% | 3057 |
|
2022
Q4 | $58K | Buy |
21,708
+8,728
| +67% | +$23.3K | ﹤0.01% | 2232 |
|
2022
Q3 | $43K | Buy |
12,980
+10,012
| +337% | +$33.2K | ﹤0.01% | 3298 |
|
2022
Q2 | $11K | Buy |
2,968
+1,778
| +149% | +$6.59K | ﹤0.01% | 4350 |
|
2022
Q1 | $6K | Buy |
1,190
+33
| +3% | +$166 | ﹤0.01% | 4847 |
|
2021
Q4 | $9K | Buy |
+1,157
| New | +$9K | ﹤0.01% | 4673 |
|
2021
Q3 | – | Sell |
-9,854
| Closed | -$182K | – | 5750 |
|
2021
Q2 | $182K | Buy |
+9,854
| New | +$182K | ﹤0.01% | 1997 |
|